News from merck
A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages
24 Jun, 2017, 18:17 BST Merck to Present Data on MAVENCLAD™ (Cladribine Tablets) and Rebif® (interferon beta-1a) in Patients with Relapsing MS at EAN Congress 2017
New data builds on company's longstanding commitment to MS Merck, a leading science and technology company, will present data from its neurology and...
28 Apr, 2017, 14:00 BST Investigational Cladribine Tablets Data Show Greater Treatment Effect in Relapsing MS Patients at a Higher Risk of Disease Progression
Subgroup analysis shows >80% reduction in the risk of disability progression with Cladribine Tablets vs placebo Merck, a leading science and...